These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11428175)

  • 1. Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable?
    Lobo RA; Whitehead MI
    Climacteric; 2001 Jun; 4(2):110-9. PubMed ID: 11428175
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone therapy: the next chapter. Is it time to rewrite the book on postmenopausal hormone use?
    Harv Womens Health Watch; 2011 Mar; 18(7):1-3. PubMed ID: 21526525
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of long-term and low-dose hormone replacement therapy on bone mineral density in postmenopausal women].
    Nie M; Sun ML; Ge QS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):421-4. PubMed ID: 16900649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women].
    Zhang YW
    Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):487-8. PubMed ID: 14627037
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical practice. Postmenopausal hormone-replacement therapy.
    Manson JE; Martin KA
    N Engl J Med; 2001 Jul; 345(1):34-40. PubMed ID: 11439947
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women.
    Marque V; Alhenc-Gelas M; Plu-Bureau G; Oger E; Scarabin PY
    Thromb Haemost; 2001 Aug; 86(2):713-4. PubMed ID: 11522028
    [No Abstract]   [Full Text] [Related]  

  • 9. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
    Ettinger B
    Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone alternative doesn't worsen vasomotor symptoms or impact urinary incontinence in post-menopausal women.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Mar; 15(5):7-9. PubMed ID: 15025087
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The endocrinological and physiological changes in menopause].
    Huhtaniemi I
    Duodecim; 1996; 112(12):1043-51. PubMed ID: 10593004
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone replacement therapy after menopause].
    Emons G
    Dtsch Med Wochenschr; 2001 Mar; 126(9):253-4. PubMed ID: 11256041
    [No Abstract]   [Full Text] [Related]  

  • 18. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
    Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
    Koh KK; Han SH; Shin MS; Ahn JY; Lee Y; Shin EK
    Eur Heart J; 2005 Jul; 26(14):1362-8. PubMed ID: 15872028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.